Enteral Feeding Devices Market by Type (Feeding Tubes (NG, NJ, OG, Gastronomy), Pumps: Feeding, Syringes; Consumables), Age (Neonates, Pediatric, Adult), Application (Oncology, GIT, Neuro, Diabetes), End User (Hospitals, Home, ASC) - Global Forecast to 2030
The global market for enteral feeding devices is projected to reach USD 3,994.2 million by 2030, from USD 2,965.1 million in 2025. This expansion is largely driven by advancements in medical technology, which have made enteral feeding systems safer, more effective, and easier for caregivers and family members to manage. Rigorous specifications from healthcare authorities ensure that these systems meet high standards of safety and efficiency. Other factors contributing to market growth include competition within the industry, demographic shifts, economic factors, globalization, patient-centered design, digital integration, and sustainability considerations.
“Enteral feeding tubes to be largest segment during forecast period”
The enteral feeding tubes segment is projected to hold the largest share of the enteral feeding devices market between 2025 and 2030. Key factors driving this trend include the increased prevalence of chronic illnesses, the rise in geriatric population, rapid advancements in technology, a surge in home health care, pediatric applications, heightened awareness of nutritional management, compliance with regulations, and increased health care spending. Manufacturers will need to innovate flexibly to meet diverse patient needs while ensuring safety and usability in various clinical settings, influenced by the global evolution of these factors.
“Oncology to surpass other applications during forecast period”
In 2024, the oncology segment accounted for the largest share of the enteral feeding devices market, and this trend is expected to continue during the forecast period. The factors influencing enteral feeding practices in oncology include nutritional support for the cancer treatment patient, enhanced recovery after surgery protocol, management of cancer-related malnutrition, technological advances, individualized nutritional planning, integration of enteral feeding with palliative care, economic issues, regulatory support, patient education, and other related ongoing research and development. These factors facilitate the effective utilization of enteral feeding to enhance the patient’s quality of life and outcomes pertaining to a cancer diagnosis.
“Hospitals & surgical centers segment to be prevalent during forecast period”
Hospitals & surgical centers are expected to be the largest segment in the enteral feeding devices market during the forecast period. The increasing use of enteral feeding in these facilities is primarily due to its positive impact on patient outcomes and the resulting cost savings in healthcare. Other contributing factors include compliance with regulations, advancements in technology, enhancements in patient safety and comfort, increased awareness and education about enteral feeding, integration with electronic health records (EHR), government initiatives, patient-centered care models, and collaboration among healthcare professionals. As these factors evolve, enteral feeding will continue to play a crucial role in patient care in hospitals and surgical centers.
“Asia Pacific to register significant growth during forecast period”
The Asia Pacific region, comprising Japan, India, China, South Korea, Australia, and the Rest of Asia Pacific, is anticipated to experience substantial growth during the forecast period. The region has experienced a notable acceleration in the market growth rate for enteral feeding devices. Contributing factors include demographic changes, economic growth, increased affordability, advancements in technology, regulatory frameworks, improved healthcare awareness, the expansion of healthcare services, enhanced trade and market access, and various government initiatives. Together, these factors create a highly dynamic market that fosters innovation and growth opportunities for both local and international companies.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
The report aims to assist new entrants, smaller firms, and market leaders in evaluating investment opportunities within the enteral feeding devices market. It offers a thorough analysis of comprehensive data, enabling informed investment decisions and effective risk assessment. By providing detailed market segmentation that includes end-user categories and regional considerations, the report offers tailored insights for precise targeting of specific segments. Additionally, it delivers an extensive evaluation of key trends, challenges, growth factors, and opportunities, empowering strategic decision-making with a clear understanding.
The report provides insights on the following pointers:
“Enteral feeding tubes to be largest segment during forecast period”
The enteral feeding tubes segment is projected to hold the largest share of the enteral feeding devices market between 2025 and 2030. Key factors driving this trend include the increased prevalence of chronic illnesses, the rise in geriatric population, rapid advancements in technology, a surge in home health care, pediatric applications, heightened awareness of nutritional management, compliance with regulations, and increased health care spending. Manufacturers will need to innovate flexibly to meet diverse patient needs while ensuring safety and usability in various clinical settings, influenced by the global evolution of these factors.
“Oncology to surpass other applications during forecast period”
In 2024, the oncology segment accounted for the largest share of the enteral feeding devices market, and this trend is expected to continue during the forecast period. The factors influencing enteral feeding practices in oncology include nutritional support for the cancer treatment patient, enhanced recovery after surgery protocol, management of cancer-related malnutrition, technological advances, individualized nutritional planning, integration of enteral feeding with palliative care, economic issues, regulatory support, patient education, and other related ongoing research and development. These factors facilitate the effective utilization of enteral feeding to enhance the patient’s quality of life and outcomes pertaining to a cancer diagnosis.
“Hospitals & surgical centers segment to be prevalent during forecast period”
Hospitals & surgical centers are expected to be the largest segment in the enteral feeding devices market during the forecast period. The increasing use of enteral feeding in these facilities is primarily due to its positive impact on patient outcomes and the resulting cost savings in healthcare. Other contributing factors include compliance with regulations, advancements in technology, enhancements in patient safety and comfort, increased awareness and education about enteral feeding, integration with electronic health records (EHR), government initiatives, patient-centered care models, and collaboration among healthcare professionals. As these factors evolve, enteral feeding will continue to play a crucial role in patient care in hospitals and surgical centers.
“Asia Pacific to register significant growth during forecast period”
The Asia Pacific region, comprising Japan, India, China, South Korea, Australia, and the Rest of Asia Pacific, is anticipated to experience substantial growth during the forecast period. The region has experienced a notable acceleration in the market growth rate for enteral feeding devices. Contributing factors include demographic changes, economic growth, increased affordability, advancements in technology, regulatory frameworks, improved healthcare awareness, the expansion of healthcare services, enhanced trade and market access, and various government initiatives. Together, these factors create a highly dynamic market that fosters innovation and growth opportunities for both local and international companies.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: C-level -- 27%, Director-level – 18%, and Others – 55%
- By Region: North America – 50%, Europe – 20%, Asia Pacific – 15%, Latin America – 10%, and Middle East & Africa – 5%
Research Coverage
- The report studies the enteral feeding devices market based on product, age group, application, end user, and region.
- The report analyzes drivers, restraints, opportunities, and challenges affecting the market growth.
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
- The report studies micro markets with respect to their growth trends, prospects, and contributions to the overall market.
- The report forecasts the revenue of market segments with respect to five major regions.
The report aims to assist new entrants, smaller firms, and market leaders in evaluating investment opportunities within the enteral feeding devices market. It offers a thorough analysis of comprehensive data, enabling informed investment decisions and effective risk assessment. By providing detailed market segmentation that includes end-user categories and regional considerations, the report offers tailored insights for precise targeting of specific segments. Additionally, it delivers an extensive evaluation of key trends, challenges, growth factors, and opportunities, empowering strategic decision-making with a clear understanding.
The report provides insights on the following pointers:
- Market Dynamics: Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the enteral feeding devices market
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product & service launches in the enteral feeding devices market
- Market Development: Comprehensive information about lucrative markets
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the enteral feeding devices market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Boston Scientific Corporation (US), and Baxter International Inc. (US), among others
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY RESEARCH
2.1.1.1 List of secondary sources
2.1.1.2 Key data from secondary sources
2.1.1.3 Objectives of secondary research
2.1.2 PRIMARY RESEARCH
2.1.2.1 List of primary sources (demand and supply sides)
2.1.2.2 Supply- and demand-side participants
2.1.2.3 Breakdown of primary interviews (supply side)
2.1.2.4 Breakdown of primary interviews (demand side)
2.1.2.5 Objectives of primary research
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation
2.2.1.2 Approach 2: Customer-based market estimation
2.2.1.3 Approach 3: Primary interviews
2.2.2 TOP-DOWN APPROACH
2.3 GROWTH FORECAST ASSUMPTIONS
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ENTERAL FEEDING DEVICES MARKET
4.2 ENTERAL FEEDING DEVICES MARKET, BY REGION
4.3 US ENTERAL FEEDING DEVICES MARKET, BY COUNTRY AND END USER
4.4 ENTERAL FEEDING DEVICES MARKET, BY COUNTRY
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Benefits and cost-effectiveness of enteral nutrition
5.2.1.2 High incidence of preterm births and genetic disorders in pediatric and neonatal patients
5.2.1.3 Rapid growth in geriatric population and age-related chronic diseases
5.2.1.4 Increasing prevalence of dysphagia
5.2.2 RESTRAINTS
5.2.2.1 Complications associated with enteral feeding devices
5.2.2.2 Lack of awareness about feeding tubes
5.2.3 OPPORTUNITIES
5.2.3.1 High growth opportunities in emerging economies
5.2.3.2 Growing demand for enteral feeding in home care settings
5.2.4 CHALLENGES
5.2.4.1 Insufficient reimbursement policies in emerging economies
5.2.4.2 Shortage of endoscopy specialists
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 REGULATORY LANDSCAPE
5.4.1 REGULATORY ANALYSIS
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5 REIMBURSEMENT SCENARIO
5.6 ECOSYSTEM ANALYSIS
5.7 INVESTMENT AND FUNDING SCENARIO
5.8 TECHNOLOGY ANALYSIS
5.8.1 KEY TECHNOLOGIES
5.8.1.1 Flow generation mechanisms
5.8.1.2 Flow control technologies
5.8.2 COMPLEMENTARY TECHNOLOGIES
5.8.2.1 Smart feeding pumps
5.8.2.2 Feeding tube replacement technologies
5.8.3 ADJACENT TECHNOLOGIES
5.8.3.1 Patient monitoring systems
5.8.3.2 Digital connectivity
5.8.3.3 Nutrition supplements
5.9 VALUE CHAIN ANALYSIS
5.9.1 RESEARCH AND DEVELOPMENT
5.9.2 RAW MATERIAL PROCUREMENT AND PRODUCT MANUFACTURING
5.9.3 DISTRIBUTION, MARKETING AND SALES, AND AFTER-SALES SERVICES
5.10 SUPPLY CHAIN ANALYSIS
5.10.1 PROMINENT COMPANIES
5.10.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.10.3 END USERS
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
5.11.2 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES OFFERED BY KEY PLAYERS
5.11.3 AVERAGE SELLING PRICE TREND, BY REGION
5.12 PATENT ANALYSIS
5.13 TRADE ANALYSIS
5.13.1 IMPORT SCENARIO (HS CODE 901839)
5.13.2 EXPORT SCENARIO (HS CODE 901839)
5.14 KEY CONFERENCES AND EVENTS, 2025–2026
5.15 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 BUYING CRITERIA
5.17 UNMET NEEDS AND KEY PAIN POINTS
5.18 IMPACT OF AI ON ENTERAL FEEDING DEVICES MARKET
6 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ENTERAL FEEDING TUBES
6.2.1 NASAL FEEDING TUBES
6.2.1.1 Need for short-term feeding with minimal tube replacement to drive market
6.2.2 ORAL FEEDING TUBES
6.2.2.1 Extensive use in feeding preterm babies to drive market
6.2.3 GASTRIC OR GASTROSTOMY TUBES (G-TUBES)
6.2.3.1 Escalating demand for PEG and PRG tubes to drive market
6.2.4 JEJUNOSTOMY TUBES (J-TUBES)
6.2.4.1 Trend of minimally invasive procedures to drive market
6.2.5 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES)
6.2.5.1 Reduced tube dislodgment and user-friendly feeding to drive market
6.3 ENTERAL FEEDING PUMPS
6.3.1 RAPID GROWTH IN HOME HEALTHCARE TO DRIVE MARKET
6.4 ENTERAL SYRINGE PUMPS
6.4.1 RELIANCE ON TUBE FEEDING TO DRIVE MARKET
6.5 CONSUMABLES & ACCESSORIES
6.5.1 SYRINGES
6.5.1.1 Technological improvements to drive market
6.5.2 EXTENSION SETS
6.5.2.1 Safe and flexible delivery of nutrition, fluids, and medications to drive market
6.5.3 ADAPTERS
6.5.3.1 Focus on biocompatible materials and minimally invasive designs to drive market
6.5.4 NUTRITION STRAWS
6.5.4.1 Emergence of home enteral nutrition programs to drive market
7 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP
7.1 INTRODUCTION
7.2 NEONATAL PATIENTS
7.2.1 RISE IN PRETERM BIRTHS TO DRIVE MARKET
7.3 PEDIATRIC PATIENTS
7.3.1 HEIGHTENED CONCERNS OF MALNUTRITION TO DRIVE MARKET
7.4 ADULT PATIENTS
7.4.1 HIGH BURDEN OF CHRONIC DISEASES TO DRIVE MARKET
7.5 GERIATRIC PATIENTS
7.5.1 DEMOGRAPHIC TRENDS AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
8 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 ONCOLOGY
8.2.1 INCREASED PREVALENCE OF CANCER TO DRIVE MARKET
8.3 GASTROINTESTINAL DISORDERS
8.3.1 RISE OF IRRITABLE BOWEL SYNDROME AND GASTROESOPHAGEAL REFLUX DISEASE TO DRIVE MARKET
8.4 NEUROLOGICAL DISORDERS
8.4.1 SURGE IN DEMAND FOR CLINICAL NUTRITION THERAPIES TO DRIVE MARKET
8.5 DIABETES
8.5.1 NEED FOR CONTROLLED ADMINISTRATION OF MEDICATIONS TO DRIVE MARKET
8.6 METABOLIC DISORDERS
8.6.1 GROWING INCIDENCE OF BURN INJURIES AND SEPSIS TO DRIVE MARKET
8.7 OTHER APPLICATIONS
9 ENTERAL FEEDING DEVICES MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS & SURGICAL CENTERS
9.2.1 RAPID ADOPTION OF ENTERAL FEEDING DEVICES IN INTENSIVE CARE UNITS TO DRIVE MARKET
9.3 HOME CARE
9.3.1 SUBSTANTIAL HOSPITALIZATION COSTS TO DRIVE MARKET
9.4 AMBULATORY CARE SETTINGS
9.4.1 ELEVATED DEMAND FOR SPECIALTY CARE TO DRIVE MARKET
9.5 OTHER END USERS
10 ENTERAL FEEDING DEVICES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK
10.2.2 US
10.2.2.1 Presence of major enteral feeding device providers to drive market
10.2.3 CANADA
10.2.3.1 Increasing incidence of chronic diseases such as diabetes and cancer to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK
10.3.2 GERMANY
10.3.2.1 Government initiatives enhancing domestic healthcare system to drive market
10.3.3 FRANCE
10.3.3.1 Escalating demand for early disease diagnosis to drive market
10.3.4 UK
10.3.4.1 Substantial rise in cancer and neurological disorders to drive market
10.3.5 ITALY
10.3.5.1 Elevated demand for cost-effective home care solutions to drive market
10.3.6 SPAIN
10.3.6.1 Surge in patients opting for enteral nutrition to drive market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK
10.4.2 CHINA
10.4.2.1 Growing investments in healthcare infrastructure development to drive market
10.4.3 JAPAN
10.4.3.1 Rapidly expanding geriatric population to drive market
10.4.4 INDIA
10.4.4.1 Large patient pool and increased per capita income to drive market
10.4.5 AUSTRALIA
10.4.5.1 Soaring volume of patients to drive market
10.4.6 SOUTH KOREA
10.4.6.1 Large number of private hospitals to drive market
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK
10.5.2 BRAZIL
10.5.2.1 Improving healthcare facilities to drive market
10.5.3 MEXICO
10.5.3.1 Robust healthcare system with universal health coverage to drive growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK
10.6.2 GCC COUNTRIES
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2024
11.3 REVENUE ANALYSIS, 2020–2024
11.4 MARKET SHARE ANALYSIS, 2024
11.4.1 ENTERAL FEEDING TUBES MARKET SHARE
11.4.2 ENTERAL FEEDING PUMPS MARKET SHARE
11.4.3 ENTERAL SYRINGE PUMPS MARKET SHARE
11.4.4 CONSUMABLES & ACCESSORIES MARKET SHARE
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Product footprint
11.5.5.4 Application footprint
11.5.5.5 Age group footprint
11.5.5.6 End user footprint
11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2024
11.6.5.1 List of start-ups/SMEs
11.6.5.2 Competitive benchmarking of start-ups/SMEs
11.7 COMPANY VALUATION AND FINANCIAL METRICS
11.8 PRODUCT/BRAND COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES AND APPROVALS
11.9.2 DEALS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 FRESENIUS SE & CO. KGAA
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Expansions
12.1.1.3.2 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 CARDINAL HEALTH
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches and approvals
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 NESTLЙ S.A.
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 MnM view
12.1.3.3.1 Key strengths
12.1.3.3.2 Strategic choices
12.1.3.3.3 Weaknesses and competitive threats
12.1.4 AVANOS MEDICAL, INC.
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Product launches and approvals
12.1.4.3.2 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 DANONE S.A.
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 BOSTON SCIENTIFIC CORPORATION
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.6.3.2 Expansions
12.1.7 BECTON, DICKINSON AND COMPANY
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Product launches and approvals
12.1.8 B. BRAUN MELSUNGEN AG
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.9 CONMED CORPORATION
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Deals
12.1.10 COOK MEDICAL
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.11 MOOG, INC.
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 BAXTER INTERNATIONAL INC.
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.12.3 Recent developments
12.1.12.3.1 Deals
12.1.13 VYGON
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.13.3 Recent developments
12.1.13.3.1 Deals
12.1.14 ENTERAL ACCESS TECHNOLOGIES LTD.
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.14.3 Recent developments
12.1.14.3.1 Other developments
12.1.15 FIDMI MEDICAL
12.1.15.1 Business overview
12.1.15.2 Products offered
12.1.15.3 Recent developments
12.1.15.3.1 Product launches and approvals
12.1.16 LIFEPUM MEDITECH
12.1.16.1 Business overview
12.1.16.2 Products offered
12.2 OTHER PLAYERS
12.2.1 APPLIED MEDICAL TECHNOLOGY, INC.
12.2.2 AMSINO INTERNATIONAL, INC.
12.2.3 OMEX MEDICAL TECHNOLOGY
12.2.4 DANUMED MEDIZINTECHNIK GMBH.
12.2.5 MEDLINE INDUSTRIES
12.2.6 FUJI SYSTEMS CORPORATION
12.2.7 KENTEC MEDICAL.
12.2.8 DYNAREX CORPORATION
12.2.9 VESCO MEDICAL, LLC
12.2.10 MEDELA AG
12.2.11 ALCOR SCIENTIFIC
12.2.12 ROMSONS
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY RESEARCH
2.1.1.1 List of secondary sources
2.1.1.2 Key data from secondary sources
2.1.1.3 Objectives of secondary research
2.1.2 PRIMARY RESEARCH
2.1.2.1 List of primary sources (demand and supply sides)
2.1.2.2 Supply- and demand-side participants
2.1.2.3 Breakdown of primary interviews (supply side)
2.1.2.4 Breakdown of primary interviews (demand side)
2.1.2.5 Objectives of primary research
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation
2.2.1.2 Approach 2: Customer-based market estimation
2.2.1.3 Approach 3: Primary interviews
2.2.2 TOP-DOWN APPROACH
2.3 GROWTH FORECAST ASSUMPTIONS
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ENTERAL FEEDING DEVICES MARKET
4.2 ENTERAL FEEDING DEVICES MARKET, BY REGION
4.3 US ENTERAL FEEDING DEVICES MARKET, BY COUNTRY AND END USER
4.4 ENTERAL FEEDING DEVICES MARKET, BY COUNTRY
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Benefits and cost-effectiveness of enteral nutrition
5.2.1.2 High incidence of preterm births and genetic disorders in pediatric and neonatal patients
5.2.1.3 Rapid growth in geriatric population and age-related chronic diseases
5.2.1.4 Increasing prevalence of dysphagia
5.2.2 RESTRAINTS
5.2.2.1 Complications associated with enteral feeding devices
5.2.2.2 Lack of awareness about feeding tubes
5.2.3 OPPORTUNITIES
5.2.3.1 High growth opportunities in emerging economies
5.2.3.2 Growing demand for enteral feeding in home care settings
5.2.4 CHALLENGES
5.2.4.1 Insufficient reimbursement policies in emerging economies
5.2.4.2 Shortage of endoscopy specialists
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 REGULATORY LANDSCAPE
5.4.1 REGULATORY ANALYSIS
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5 REIMBURSEMENT SCENARIO
5.6 ECOSYSTEM ANALYSIS
5.7 INVESTMENT AND FUNDING SCENARIO
5.8 TECHNOLOGY ANALYSIS
5.8.1 KEY TECHNOLOGIES
5.8.1.1 Flow generation mechanisms
5.8.1.2 Flow control technologies
5.8.2 COMPLEMENTARY TECHNOLOGIES
5.8.2.1 Smart feeding pumps
5.8.2.2 Feeding tube replacement technologies
5.8.3 ADJACENT TECHNOLOGIES
5.8.3.1 Patient monitoring systems
5.8.3.2 Digital connectivity
5.8.3.3 Nutrition supplements
5.9 VALUE CHAIN ANALYSIS
5.9.1 RESEARCH AND DEVELOPMENT
5.9.2 RAW MATERIAL PROCUREMENT AND PRODUCT MANUFACTURING
5.9.3 DISTRIBUTION, MARKETING AND SALES, AND AFTER-SALES SERVICES
5.10 SUPPLY CHAIN ANALYSIS
5.10.1 PROMINENT COMPANIES
5.10.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.10.3 END USERS
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
5.11.2 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES OFFERED BY KEY PLAYERS
5.11.3 AVERAGE SELLING PRICE TREND, BY REGION
5.12 PATENT ANALYSIS
5.13 TRADE ANALYSIS
5.13.1 IMPORT SCENARIO (HS CODE 901839)
5.13.2 EXPORT SCENARIO (HS CODE 901839)
5.14 KEY CONFERENCES AND EVENTS, 2025–2026
5.15 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 BUYING CRITERIA
5.17 UNMET NEEDS AND KEY PAIN POINTS
5.18 IMPACT OF AI ON ENTERAL FEEDING DEVICES MARKET
6 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ENTERAL FEEDING TUBES
6.2.1 NASAL FEEDING TUBES
6.2.1.1 Need for short-term feeding with minimal tube replacement to drive market
6.2.2 ORAL FEEDING TUBES
6.2.2.1 Extensive use in feeding preterm babies to drive market
6.2.3 GASTRIC OR GASTROSTOMY TUBES (G-TUBES)
6.2.3.1 Escalating demand for PEG and PRG tubes to drive market
6.2.4 JEJUNOSTOMY TUBES (J-TUBES)
6.2.4.1 Trend of minimally invasive procedures to drive market
6.2.5 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES)
6.2.5.1 Reduced tube dislodgment and user-friendly feeding to drive market
6.3 ENTERAL FEEDING PUMPS
6.3.1 RAPID GROWTH IN HOME HEALTHCARE TO DRIVE MARKET
6.4 ENTERAL SYRINGE PUMPS
6.4.1 RELIANCE ON TUBE FEEDING TO DRIVE MARKET
6.5 CONSUMABLES & ACCESSORIES
6.5.1 SYRINGES
6.5.1.1 Technological improvements to drive market
6.5.2 EXTENSION SETS
6.5.2.1 Safe and flexible delivery of nutrition, fluids, and medications to drive market
6.5.3 ADAPTERS
6.5.3.1 Focus on biocompatible materials and minimally invasive designs to drive market
6.5.4 NUTRITION STRAWS
6.5.4.1 Emergence of home enteral nutrition programs to drive market
7 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP
7.1 INTRODUCTION
7.2 NEONATAL PATIENTS
7.2.1 RISE IN PRETERM BIRTHS TO DRIVE MARKET
7.3 PEDIATRIC PATIENTS
7.3.1 HEIGHTENED CONCERNS OF MALNUTRITION TO DRIVE MARKET
7.4 ADULT PATIENTS
7.4.1 HIGH BURDEN OF CHRONIC DISEASES TO DRIVE MARKET
7.5 GERIATRIC PATIENTS
7.5.1 DEMOGRAPHIC TRENDS AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
8 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 ONCOLOGY
8.2.1 INCREASED PREVALENCE OF CANCER TO DRIVE MARKET
8.3 GASTROINTESTINAL DISORDERS
8.3.1 RISE OF IRRITABLE BOWEL SYNDROME AND GASTROESOPHAGEAL REFLUX DISEASE TO DRIVE MARKET
8.4 NEUROLOGICAL DISORDERS
8.4.1 SURGE IN DEMAND FOR CLINICAL NUTRITION THERAPIES TO DRIVE MARKET
8.5 DIABETES
8.5.1 NEED FOR CONTROLLED ADMINISTRATION OF MEDICATIONS TO DRIVE MARKET
8.6 METABOLIC DISORDERS
8.6.1 GROWING INCIDENCE OF BURN INJURIES AND SEPSIS TO DRIVE MARKET
8.7 OTHER APPLICATIONS
9 ENTERAL FEEDING DEVICES MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS & SURGICAL CENTERS
9.2.1 RAPID ADOPTION OF ENTERAL FEEDING DEVICES IN INTENSIVE CARE UNITS TO DRIVE MARKET
9.3 HOME CARE
9.3.1 SUBSTANTIAL HOSPITALIZATION COSTS TO DRIVE MARKET
9.4 AMBULATORY CARE SETTINGS
9.4.1 ELEVATED DEMAND FOR SPECIALTY CARE TO DRIVE MARKET
9.5 OTHER END USERS
10 ENTERAL FEEDING DEVICES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK
10.2.2 US
10.2.2.1 Presence of major enteral feeding device providers to drive market
10.2.3 CANADA
10.2.3.1 Increasing incidence of chronic diseases such as diabetes and cancer to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK
10.3.2 GERMANY
10.3.2.1 Government initiatives enhancing domestic healthcare system to drive market
10.3.3 FRANCE
10.3.3.1 Escalating demand for early disease diagnosis to drive market
10.3.4 UK
10.3.4.1 Substantial rise in cancer and neurological disorders to drive market
10.3.5 ITALY
10.3.5.1 Elevated demand for cost-effective home care solutions to drive market
10.3.6 SPAIN
10.3.6.1 Surge in patients opting for enteral nutrition to drive market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK
10.4.2 CHINA
10.4.2.1 Growing investments in healthcare infrastructure development to drive market
10.4.3 JAPAN
10.4.3.1 Rapidly expanding geriatric population to drive market
10.4.4 INDIA
10.4.4.1 Large patient pool and increased per capita income to drive market
10.4.5 AUSTRALIA
10.4.5.1 Soaring volume of patients to drive market
10.4.6 SOUTH KOREA
10.4.6.1 Large number of private hospitals to drive market
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK
10.5.2 BRAZIL
10.5.2.1 Improving healthcare facilities to drive market
10.5.3 MEXICO
10.5.3.1 Robust healthcare system with universal health coverage to drive growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK
10.6.2 GCC COUNTRIES
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2024
11.3 REVENUE ANALYSIS, 2020–2024
11.4 MARKET SHARE ANALYSIS, 2024
11.4.1 ENTERAL FEEDING TUBES MARKET SHARE
11.4.2 ENTERAL FEEDING PUMPS MARKET SHARE
11.4.3 ENTERAL SYRINGE PUMPS MARKET SHARE
11.4.4 CONSUMABLES & ACCESSORIES MARKET SHARE
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Product footprint
11.5.5.4 Application footprint
11.5.5.5 Age group footprint
11.5.5.6 End user footprint
11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2024
11.6.5.1 List of start-ups/SMEs
11.6.5.2 Competitive benchmarking of start-ups/SMEs
11.7 COMPANY VALUATION AND FINANCIAL METRICS
11.8 PRODUCT/BRAND COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES AND APPROVALS
11.9.2 DEALS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 FRESENIUS SE & CO. KGAA
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Expansions
12.1.1.3.2 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 CARDINAL HEALTH
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches and approvals
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 NESTLЙ S.A.
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 MnM view
12.1.3.3.1 Key strengths
12.1.3.3.2 Strategic choices
12.1.3.3.3 Weaknesses and competitive threats
12.1.4 AVANOS MEDICAL, INC.
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Product launches and approvals
12.1.4.3.2 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 DANONE S.A.
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 BOSTON SCIENTIFIC CORPORATION
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.6.3.2 Expansions
12.1.7 BECTON, DICKINSON AND COMPANY
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Product launches and approvals
12.1.8 B. BRAUN MELSUNGEN AG
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.9 CONMED CORPORATION
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Deals
12.1.10 COOK MEDICAL
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.11 MOOG, INC.
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 BAXTER INTERNATIONAL INC.
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.12.3 Recent developments
12.1.12.3.1 Deals
12.1.13 VYGON
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.13.3 Recent developments
12.1.13.3.1 Deals
12.1.14 ENTERAL ACCESS TECHNOLOGIES LTD.
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.14.3 Recent developments
12.1.14.3.1 Other developments
12.1.15 FIDMI MEDICAL
12.1.15.1 Business overview
12.1.15.2 Products offered
12.1.15.3 Recent developments
12.1.15.3.1 Product launches and approvals
12.1.16 LIFEPUM MEDITECH
12.1.16.1 Business overview
12.1.16.2 Products offered
12.2 OTHER PLAYERS
12.2.1 APPLIED MEDICAL TECHNOLOGY, INC.
12.2.2 AMSINO INTERNATIONAL, INC.
12.2.3 OMEX MEDICAL TECHNOLOGY
12.2.4 DANUMED MEDIZINTECHNIK GMBH.
12.2.5 MEDLINE INDUSTRIES
12.2.6 FUJI SYSTEMS CORPORATION
12.2.7 KENTEC MEDICAL.
12.2.8 DYNAREX CORPORATION
12.2.9 VESCO MEDICAL, LLC
12.2.10 MEDELA AG
12.2.11 ALCOR SCIENTIFIC
12.2.12 ROMSONS
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
